Immunology

How the 'Iron Man' of immune cells helps T cells fight infection

The immune system's killer T cells are crucial in fighting viral infections. A fraction of them, called 'memory cells', live on once infection is controlled in order to fight re-infection by the same virus. They are of great ...

Immunology

Scientists stumble upon a model to study a lethal complication

More and more hospitalized patients with sepsis are being diagnosed with a deadly complication characterized by high levels of inflammation. A team of Yale researchers has uncovered clues to the cause of this complication—which ...

Diseases, Conditions, Syndromes

CDC: Proportion of increased-risk deceased organ donors on rise

(HealthDay)—Among deceased organ donors, there has been an increase in the proportion at increased risk for transmitting hepatitis B virus (HBV), hepatitis C virus (HCV), and HIV to recipients, according to research published ...

Cancer

Many hepatitis infections go undiagnosed in cancer patients

Results from the largest study of hepatitis B and C and HIV infection prevalence in cancer patients show an alarmingly high rate of undiagnosed acute and chronic hepatitis B and C. Hepatitis B and C are serious but treatable ...

Diseases, Conditions, Syndromes

Cellular protein a target for Zika control

A cellular protein that interacts with invading viruses appears to help enable the infection process of the Zika virus, according to an international team of researchers who suggest this protein could be a key target in developing ...

Diseases, Conditions, Syndromes

RNA processing and antiviral immunity

The RIG-I like receptors (RLRs) are intracellular enzyme sentries that detect viral infection and initiate a first line of antiviral defense. The cellular molecules that activate RLRs in vivo are not clear.

Diseases, Conditions, Syndromes

Reducing unnecessary medication for hepatitis B patients

Not all chronic hepatitis B (HBV) patients require lifelong treatment; but the risks of blindly withdrawing treatment can be severe. However, there's little consensus on which patients can be safely discontinued from treatment, ...

page 1 from 23